These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Comparative clinical study with iotrolan versus metrizamide in lumbar myelography.
    Author: Inoue S, Watanabe T, Yamamura H.
    Journal: Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():161-6. PubMed ID: 2568787.
    Abstract:
    In order to examine the radiopacity, safety, and usefulness of iotrolan, a new dimeric, nonionic, water-soluble contrast medium for myelography, a multicenter clinical study was performed in lumbar myelography using metrizamide as the reference drug. Both media were injected at a strength of 190 mg I/ml in 90 patients each. Both contrast media showed good opacification; there was no significant difference between the two media. The incidence and severity of side effects were significantly lower with iotrolan than those with metrizamide. No severe side effects, such as convulsion and shock, were observed with either medium.
    [Abstract] [Full Text] [Related] [New Search]